Es gab 50 kürzliche Insider-Transaktionen für Coya Therapeutics, Inc. (COYA), darunter 45 Käufe und 2 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $14.2M und die gesamten Insider-Verkäufe auf $594.49K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Snyder David S, Berman Howard, Grossman Fred. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — COYA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-01-22 |
Snyder David S |
Chief Financial Officer |
RSU-Zuteilung |
140,041 |
$4.73 |
$662.39K |
140,041 |
| 2026-01-22 |
Berman Howard |
Executive Chairman |
RSU-Zuteilung |
15,257 |
$4.73 |
$72.17K |
15,257 |
| 2026-01-22 |
Grossman Fred |
Chief Medical Officer |
RSU-Zuteilung |
140,041 |
$4.73 |
$662.39K |
140,041 |
| 2026-01-22 |
Swaminathan Arun |
Chief Executive Officer |
RSU-Zuteilung |
293,983 |
$4.73 |
$1.39M |
293,983 |
| 2026-01-02 |
Ross Wilbur L Jr |
Director |
RSU-Zuteilung |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Goldstein Dov A Md |
Director |
RSU-Zuteilung |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Weinand Dieter |
Director |
RSU-Zuteilung |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Villalobos Anabella |
Director |
RSU-Zuteilung |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2026-01-02 |
Lee Ann |
Director |
RSU-Zuteilung |
10,000 |
$5.65 |
$56.5K |
10,000 |
| 2025-08-18 |
Goldstein Dov A Md |
Director |
Optionsausübung (Verkauf) |
17,557 |
$1.09 |
$19.14K |
- |
| 2025-02-25 |
Ross Wilbur L Jr |
Director |
RSU-Zuteilung |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Goldstein Dov A Md |
Director |
RSU-Zuteilung |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Weinand Dieter |
Director |
RSU-Zuteilung |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Villalobos Anabella |
Director |
RSU-Zuteilung |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-02-25 |
Lee Ann |
Director |
RSU-Zuteilung |
5,000 |
$5.97 |
$29.85K |
5,000 |
| 2025-01-09 |
Snyder David S |
Chief Financial Officer |
RSU-Zuteilung |
140,562 |
$6.07 |
$853.21K |
140,562 |
| 2025-01-09 |
Berman Howard |
Director |
RSU-Zuteilung |
150,602 |
$6.07 |
$914.15K |
150,602 |
| 2025-01-09 |
Grossman Fred |
Chief Medical Officer |
RSU-Zuteilung |
140,562 |
$6.07 |
$853.21K |
140,562 |
| 2025-01-09 |
Swaminathan Arun |
Chief Executive Officer |
RSU-Zuteilung |
240,964 |
$6.07 |
$1.46M |
240,964 |
| 2025-01-01 |
Ross Wilbur L Jr |
Director |
RSU-Zuteilung |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Goldstein Dov A Md |
Director |
RSU-Zuteilung |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Weinand Dieter |
Director |
RSU-Zuteilung |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Villalobos Anabella |
Director |
RSU-Zuteilung |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2025-01-01 |
Lee Ann |
Director |
RSU-Zuteilung |
5,000 |
$5.73 |
$28.65K |
5,000 |
| 2024-11-14 |
Snyder David S |
Chief Financial Officer |
Informierter Kauf |
1,800 |
$7.19 |
$12.93K |
8,800 |
| 2024-11-13 |
Swaminathan Arun |
Chief Executive Officer |
Informierter Kauf |
5,000 |
$7.36 |
$36.8K |
10,000 |
| 2024-11-11 |
Grossman Fred |
Chief Medical Officer |
Informierter Kauf |
2,710 |
$7.37 |
$19.97K |
2,710 |
| 2024-11-11 |
Swaminathan Arun |
Chief Executive Officer |
Informierter Kauf |
5,000 |
$7.34 |
$36.69K |
5,000 |
| 2024-08-19 |
Swaminathan Arun |
Director |
Veräußerung |
70,596 |
$8.15 |
$575.36K |
- |
| 2024-06-03 |
Snyder David S |
Chief Financial Officer |
RSU-Zuteilung |
70,596 |
$8.15 |
$575.36K |
70,596 |
| 2024-06-03 |
Berman Howard |
Chief Executive Officer |
RSU-Zuteilung |
163,663 |
$8.15 |
$1.33M |
163,663 |
| 2024-06-03 |
Grossman Fred |
Chief Medical Officer |
RSU-Zuteilung |
70,596 |
$8.15 |
$575.36K |
70,596 |
| 2024-01-31 |
Snyder David S |
Chief Financial Officer |
RSU-Zuteilung |
81,819 |
$5.90 |
$482.73K |
81,819 |
| 2024-01-31 |
Berman Howard |
Chief Executive Officer |
RSU-Zuteilung |
189,680 |
$5.90 |
$1.12M |
189,680 |
| 2024-01-31 |
Grossman Fred |
Chief Medical Officer |
RSU-Zuteilung |
74,069 |
$5.90 |
$437.01K |
74,069 |
| 2024-01-02 |
Ross Wilbur L Jr |
Director |
RSU-Zuteilung |
10,000 |
$6.97 |
$69.7K |
10,000 |
| 2024-01-01 |
Goldstein Dov A Md |
Director |
RSU-Zuteilung |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Weinand Dieter |
Director |
RSU-Zuteilung |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Garren Hideki |
Director |
RSU-Zuteilung |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Villalobos Anabella |
Director |
RSU-Zuteilung |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2024-01-01 |
Lee Ann |
Director |
RSU-Zuteilung |
5,000 |
$7.41 |
$37.05K |
5,000 |
| 2023-12-19 |
Ross Wilbur L Jr |
Director |
Unbekannt |
- |
- |
- |
165,016 |
| 2023-08-22 |
Lee Ann |
Director |
Informierter Kauf |
1,000 |
$3.62 |
$3.62K |
17,479 |
| 2023-08-18 |
Weinand Dieter |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-08-18 |
Weinand Dieter |
Director |
RSU-Zuteilung |
10,000 |
$3.43 |
$34.3K |
10,000 |
| 2023-07-17 |
Grossman Fred |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-07-17 |
Grossman Fred |
Chief Medical Officer |
RSU-Zuteilung |
74,069 |
$4.25 |
$314.79K |
74,069 |
| 2023-02-27 |
Snyder David S |
Chief Financial Officer |
RSU-Zuteilung |
115,000 |
$3.85 |
$442.75K |
115,000 |
| 2023-02-27 |
Hepner Adrian |
Chief Medical Officer |
RSU-Zuteilung |
115,000 |
$3.85 |
$442.75K |
115,000 |
| 2023-02-27 |
Berman Howard |
Chief Executive Officer |
RSU-Zuteilung |
165,000 |
$3.85 |
$635.25K |
165,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
